vx-150
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02660424)
Timeline
Indications
Mechanism of action
SCN10A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vx-150
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06420765 | Phase 1 | May 21, 2024 | Vertex |
| NCT05418712 | Phase 1 | Jun 16, 2022 | Vertex |
| NCT03764072 | Phase 2 | Nov 30, 2018 | Vertex |
| NCT03304522 | Phase 2 | Sep 25, 2017 | Vertex |
| NCT03206749 | Phase 2 | Jun 29, 2017 | Vertex |
| NCT02660424 | Phase 2 | Dec 1, 2015 | Vertex |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vertex | For profit | 6 | 6 | 2 | 2015 |
1 organizations
Page 1 / 1